Lifecycle Management as a Roadmap to the Tobacco Endgame

World Journal of Clinical Medicine Research | Vol 5, Issue 1

Table 4. Zachman Cell Measures with Data SourceExamples

Lifecycle Phase	Interrogative	Measures	Variables	Potential Data Sources / AI Search Examples
1. Conception & Initiation	What	Availability of baseline prevalence & mortality datasets; Endgame policy concept papers produced	% of states with current prevalence data; # of policy concept papers published	CDC NHIS, BRFSS, STATE System for prevalence; state health dept reports; Surgeon General reports
	How	Quality of stakeholder engagement processes	# of stakeholder meetings; % of priority stakeholders engaged	NAQC quitline annual survey; minutes from state tobacco control coalition meetings
	Where	Geographic coverage of baseline data	% of states with reliable baseline prevalence measures	CDC STATE maps; county-level BRFSS prevalence data
	Who	Diversity of engaged stakeholder groups	# of unique stakeholder categories (gov, NGO, research, community)	NAQC survey partner lists; state tobacco advisory board rosters
	When	Time from problem identification to initial strategy draft	Avg. months elapsed	Legislative records; news archives; HHS press releases
	Why	Specificity of mission statements	% of mission statements with measurable targets	State tobacco control plans; CDC OSH national strategy documents
2. Policy & System Design	What	Completeness of draft legislation & regulatory frameworks	% of FCTC-recommended measures included; # of policy gaps identified	CDC STATE System policy coverage; state legislative tracking (NCSL)
	How	Process adherence to regulatory impact assessment standards	% of policy drafts with documented impact analysis; review cycle time (days)	Federal Register entries; GAO reports on tobacco regulation
	Where	State-level alignment with federal frameworks	% of states with harmonized endgame policies	CDC STATE policy alignment datasets
	Who	Representation in policy design forums	% of policy design meetings with multi-sector participation	Legislative hearing transcripts; public comment registries
	When	Policy drafting cycle time	Avg. days from drafting start to legislative submission	Bill histories from Congress.gov and state legislature portals
	Why	Alignment of policy goals with national health targets	% of goals tied to Healthy People or FCTC objectives	State tobacco plans vs Healthy People TU objectives
3. Implementation & Operation	What	Campaign material coverage; Quitline/NRT resource stock	% of population reached by campaigns; NRT supply adequacy index	CampaignReach metrics; NAQC Quitline reports; NRT distribution records
	How	Campaign deployment effectiveness; Compliance inspection coverage	% of planned campaigns delivered; # of inspections per 1,000 retailers	FDA Tobacco Compliance Check database; campaign progress reports
	Where	Geographic reach of campaigns and enforcement	% of population in covered jurisdictions; inspections per region	FDA inspection location data + Census population maps
	Who	Stakeholder participation in campaign delivery	% of NGOs actively delivering campaign components	NAQC program participation data
	When	Campaign and inspection timeliness	% of activities delivered on schedule	Campaign schedules; FDA enforcement calendar
	Why	Alignment of program KPIs to strategic goals	% of program KPIs mapping to national endgame targets	State DOH performance plans; CDC OSH performance dashboards
4. Evaluation & Adaptation	What	Timeliness and completeness of surveillance datasets	Avg. lag (months) between data collection and release; % of data fields complete	CDC YRBSS, NYTS release calendars; STATE System update logs
	How	Responsiveness of policy adjustments	Avg. time from new threat detection to policy update	FDA guidance issuance timelines; policy change notices
	Where	Distribution of data collection sites	% of counties with active surveillance points	YRBSS site list; state survey sampling frames
	Who	Multi-stakeholder involvement in evaluation	% of evaluation panels with non-gov participants	Panel rosters; evaluation meeting minutes
	When	Speed of response to emerging threats	Avg. days to policy update after detection	DOJ/FDA illicit trade enforcement announcements
	Why	Use of evaluation findings to adjust goals	% of updated goals following evaluation cycles	Revision histories in state tobacco control plans
5. Consolidation & Endgame Transition	What	Endgame law enactment rate; Supply reduction instruments in place	% of endgame measures legislated; # of retail outlets under supply quotas	CDC policy tracking; state licensing data
	How	Execution speed of final cessation pushes	% of remaining smokers reached with targeted support; weeks to implement supply quota	State cessation program reports; NRT procurement records
	Where	Cross-border enforcement coverage	# of customs checkpoints integrated into enforcement plan	CBP operation logs; DOJ task force reports
	Who	Cross-agency coordination effectiveness	# of joint operations conducted; % of joint objectives met	MOUs; joint task force meeting reports
	When	Synchronization of final measures nationally	% of states implementing endgame measures within target window	Policy adoption timelines from CDC STATE
	Why	Goal clarity in final push phase	% of endgame policies with specific prevalence targets	Legislative text review; agency strategic plans
6. Sustainment / Sunset	What	Post-endgame monitoring systems operational	% of illicit trade cases detected vs prosecuted; # of norm reinforcement materials issued/year	CBP/DOJ enforcement stats; public health education archives
	How	Continuity of surveillance and education	% of planned monitoring events completed; % of educational programs renewed annually	Surveillance schedules; funding renewal records
	Where	Post-endgame coverage of illicit trade monitoring	% of high-risk border zones under continuous monitoring	CBP surveillance maps; enforcement jurisdiction reports
	Who	Community engagement in sustaining tobacco-free norms	% of community groups funded for prevention activities	Grant award databases; program rosters
	When	Frequency of post-endgame monitoring events	Avg. interval (months) between surveillance reports	Report publication dates
	Why	Maintenance of post-endgame vision	% of strategic plans including relapse prevention objectives	Strategic plan review; public health policy archives